litlas
Log inCreate account

Maria E. Arcila

Active 2009–2025

187
Papers
47,062
Citations
104
h-index
182
i10-index

Citations

Citations per year for Maria E. Arcila1976: 3 citations1991: 1 citations1992: 1 citations1993: 1 citations1997: 1 citations1998: 3 citations1999: 2 citations2000: 2 citations2004: 2 citations2007: 2 citations2008: 1 citations2009: 2 citations2010: 10 citations2011: 58 citations2012: 123 citations2013: 284 citations2014: 279 citations2015: 416 citations2016: 514 citations2017: 596 citations2018: 843 citations2019: 2,455 citations2020: 3,054 citations2021: 2,975 citations2022: 2,329 citations2023: 1,770 citations2024: 2,562 citations2025: 1,261 citations2026: 42 citations1977–1990: no citations, so these years are not shown1994–1996: no citations, so these years are not shown2001–2003: no citations, so these years are not shown2005–2006: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,923 citing papers, 29.3% of this breakdownChina: 2,735 citing papers, 11.6% of this breakdownItaly: 1,308 citing papers, 5.5% of this breakdownUnited Kingdom: 1,184 citing papers, 5% of this breakdownGermany: 1,133 citing papers, 4.8% of this breakdownFrance: 1,001 citing papers, 4.2% of this breakdownJapan: 992 citing papers, 4.2% of this breakdownSpain: 812 citing papers, 3.5% of this breakdownCanada: 760 citing papers, 3.2% of this breakdownNetherlands: 597 citing papers, 2.5% of this breakdownSwitzerland: 549 citing papers, 2.3% of this breakdownSouth Korea: 549 citing papers, 2.3% of this breakdown
0%29.3%Other 21.6%

Institutions

Fields

  • Medicine70.5%
  • Biochemistry, Genetics and Molecular Biology24.3%
  • Immunology and Microbiology2.7%
  • Computer Science0.8%
  • Engineering0.4%
  • Chemistry0.3%
  • Other1%

Topics

  • Lung Cancer Treatments and Mutations10.1%
  • Cancer Genomics and Diagnostics7.6%
  • Cancer Immunotherapy and Biomarkers4.2%
  • Lung Cancer Research Studies3.6%
  • CAR-T cell therapy research3.5%
  • Lung Cancer Diagnosis and Treatment2.3%
  • Other68.7%

Coauthors

All papers

Open in search
  1. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

    Authors: Ahmet Zehir, Ryma Benayed, Ronak Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R. Kim, Preethi Srinivasan, Jianjiong Gao, Debyani Chakravarty, Sean M. Devlin, Matthew D. Hellmann, David Barron, Alison M. Schram, Meera Hameed, Snjezana Doğan, Dara S. Ross, Jaclyn F. Hechtman, Deborah F. DeLair, JinJuan Yao, Diana Mandelker, Donavan T. Cheng, Raghu Chandramohan, Abhinita Mohanty, Ryan Ptashkin, Gowtham Jayakumaran, Meera Prasad, Mustafa Syed, Anoop Balakrishnan Rema, Zhen Y. Liu, Khédoudja Nafa, Laetitia Borsu, Justyna Sadowska, Jacklyn Casanova, Ruben Bacares, Iwona Kiecka, Anna Razumova, Julie B Son, Lisa Stewart, Tessara Baldi, Kerry Mullaney, Hikmat Al‐Ahmadie, Efsevia Vakiani, Adam Abeshouse, Alexander Penson, Philip Jonsson, Niedzica Camacho, Matthew T. Chang, Helen Won, Benjamin Groß, Ritika Kundra, Zachary Heins, Hsiao‐Wei Chen, Sarah Phillips, Hongxin Zhang, Jiaojiao Wang, Angelica Ochoa, Jonathan Wills, Michael Eubank, Stacy B. Thomas, Stuart M. Gardos, Dalicia N. Reales, Jesse Galle, Robert Durany, Roy Cambria, Wassim Abida, Andrea Cercek, Darren R. Feldman, Mrinal M. Gounder, A. Ari Hakimi, James J. Harding, Gopa Iyer, Yelena Y. Janjigian, Emmet Jordan, Ciara M. Kelly, Maeve A. Lowery, Luc G.T. Morris, Antonio Omuro, Nitya Raj, Pedram Razavi, Alexander N. Shoushtari, Neerav Shukla, Tara E. Soumerai, Anna M. Varghese, Rona Yaeger, Jonathan Coleman, Bernard H. Bochner, Gregory J. Riely, Leonard B. Saltz, Howard I. Scher, Paul Sabbatini, Mark E. Robson, David S. Klimstra, Barry S. Taylor, José Baselga, Nikolaus Schultz, David M. Hyman, Maria E. Arcila, David B. Solit, Marc Ladanyi, Michael F. Berger - Nature Medicine 2017 cited by 3,517

  2. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)

    Authors: Donavan T. Cheng, Talia Mitchell, Ahmet Zehir, Ronak Shah, Ryma Benayed, Aijazuddin Syed, Raghu Chandramohan, Zhen Yu Liu, Helen Won, Sasinya N. Scott, A. Rose Brannon, Catherine O’Reilly, Justyna Sadowska, Jacklyn Casanova, Angela Yannes, Jaclyn F. Hechtman, JinJuan Yao, Wei Song, Dara S. Ross, Alifya Oultache, Snjezana Doğan, Laetitia Borsu, Meera Hameed, Khédoudja Nafa, Maria E. Arcila, Marc Ladanyi, Michael F. Berger - Journal of Molecular Diagnostics 2015 cited by 2,155

  3. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

    Authors: Marco L. Davila, Isabelle Rivière, Xiuyan Wang, Shirley Bartido, Jae H. Park, Kevin J. Curran, Stephen S. Chung, Jolanta Stefanski, Oriana Bórquez-Ojeda, Malgorzata Olszewska, Jinrong Qu, Teresa Wasielewska, Qing He, Mitsú J. Fink, Himaly Shinglot, Maher Youssif, Mark Satter, Yongzeng Wang, James Hosey, Hilda Quintanilla, Elizabeth Halton, Yvette Bernal, Diana Bouhassira, Maria E. Arcila, Mithat Gönen, Gail J. Roboz, P. Maslak, Dan Douer, Mark G. Frattini, Sergio Giralt, Michel Sadelain, Renier J. Brentjens - Science Translational Medicine 2014 cited by 2,497

  4. Cancer therapy shapes the fitness landscape of clonal hematopoiesis

    Authors: Kelly L. Bolton, Ryan Ptashkin, Teng Gao, Lior Z. Braunstein, Sean M. Devlin, Daniel J. Kelly, Minal Patel, Antonin Berthon, Aijazuddin Syed, Mariko Yabe, Catherine C. Coombs, Nicole M. Caltabellotta, Mike Walsh, Kenneth Offit, Zsofia K. Stadler, Diana Mandelker, Jessica Schulman, Akshar Patel, John Philip, Elsa Bernard, Gunes Gundem, Juan Arango Ossa, Max F. Levine, Juan Martínez, Noushin Farnoud, Dominik Głodzik, Sonya Li, Mark E. Robson, Choonsik Lee, Paul D.P. Pharoah, Konrad H. Stopsack, Barbara Spitzer, Simon Mantha, James A. Fagin, Laura Boucai, Christopher J. Gibson, Benjamin L. Ebert, Andrew L. Young, Todd E. Druley, Koichi Takahashi, Nancy Gillis, Markus Ball, Eric Padron, David M. Hyman, José Baselga, Larry Norton, Stuart M. Gardos, Virginia M. Klimek, Howard I. Scher, Dean F. Bajorin, Eder Paraiso, Ryma Benayed, Maria E. Arcila, Marc Ladanyi, David B. Solit, Michael F. Berger, Martin S. Tallman, Montserrat García‐Closas, Nilanjan Chatterjee, Luis A. Díaz, Ross L. Levine, Lindsay M. Morton, Ahmet Zehir, Elli Papaemmanuil - Nature Genetics 2020 cited by 741

  5. Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes

    Authors: Catherine C. Coombs, Ahmet Zehir, Sean M. Devlin, Ashwin Kishtagari, Aijazuddin Syed, Philip Jonsson, David M. Hyman, David B. Solit, Mark E. Robson, José Baselga, Maria E. Arcila, Marc Ladanyi, Martin S. Tallman, Ross L. Levine, Michael F. Berger - Cell stem cell 2017 cited by 855

  6. Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

    Authors: Christian Rolfo, Philip C. Mack, Giorgio V. Scagliotti, Charu Aggarwal, Maria E. Arcila, Fabrice Barlési, Trever G. Bivona, Maximilian Diehn, Caroline Dive, Rafał Dziadziuszko, Natasha B. Leighl, Umberto Malapelle, Tony Mok, Nir Peled, Luis E. Raez, Lecia V. Sequist, Lynette M. Sholl, Charles Swanton, Chris Abbosh, Daniel S.W. Tan, Heather A. Wakelee, Ignacio I. Wistuba, Rebecca A. Bunn, Janet Freeman‐Daily, Murry W. Wynes, Chandra P. Belani, Tetsuya Mitsudomi, David R. Gandara - Journal of Thoracic Oncology 2021 cited by 645

  7. Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing

    Authors: Hira Rizvi, Francisco Sánchez-Vega, Konnor La, Walid K. Chatila, Philip Jonsson, Darragh Halpenny, Andrew J. Plodkowski, Niamh M. Long, Jennifer L. Sauter, Natasha Rekhtman, Travis J. Hollmann, Kurt A. Schalper, Justin F. Gainor, Ronglai Shen, Ai Ni, Kathryn C. Arbour, Taha Merghoub, Jedd D. Wolchok, Alexandra Snyder, Jamie E. Chaft, Mark G. Kris, Charles M. Rudin, Nicholas D. Socci, Michael F. Berger, Barry S. Taylor, Ahmet Zehir, David B. Solit, Maria E. Arcila, Marc Ladanyi, Gregory J. Riely, Nikolaus Schultz, Matthew D. Hellmann - Journal of Clinical Oncology 2018 cited by 1,421

  8. Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR -Mutant Lung Cancers

    Authors: Helena A. Yu, Maria E. Arcila, Natasha Rekhtman, Camelia S. Sima, Maureen F. Zakowski, William Pao, Mark G. Kris, Vincent A. Miller, Marc Ladanyi, Gregory J. Riely - Clinical Cancer Research 2013 cited by 2,475

  9. Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer

    Authors: Sarah P. Suehnholz, Moriah H. Nissan, Hongxin Zhang, Ritika Kundra, Subhiksha Nandakumar, Calvin Lu, Stephanie Carrero, Amanda Dhaneshwar, Nicole Fernandez, Benjamin W. Xu, Maria E. Arcila, Ahmet Zehir, Aijazuddin Syed, A. Rose Brannon, Julia E. Rudolph, Eder Paraiso, Paul Sabbatini, Ross L. Levine, Ahmet Doǧan, Jianjiong Gao, Marc Ladanyi, Alexander Drilon, Michael F. Berger, David B. Solit, Nikolaus Schultz, Debyani Chakravarty - Cancer Discovery 2023 cited by 391

  10. Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR -Mutant Lung Cancer

    Authors: Adam J. Schoenfeld, Joseph M. Chan, Daisuke Kubota, Hiroki Sato, Hira Rizvi, Yahya Daneshbod, Jason C. Chang, Paul K. Paik, Michael Offin, Maria E. Arcila, Monika A. Davare, Ujwal Shinde, Dana Pe’er, Natasha Rekhtman, Mark G. Kris, Romel Somwar, Gregory J. Riely, Marc Ladanyi, Helena A. Yu - Clinical Cancer Research 2020 cited by 383

  11. HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

    Authors: Bob T. Li, Flavia Michelini, Sandra Misale, Emiliano Cocco, Laura Baldino, Yanyan Cai, Sophie Shifman, Hai‐Yan Tu, Mackenzie L. Myers, Chong‐Rui Xu, Marissa S. Mattar, Inna Khodos, Megan Little, Besnik Qeriqi, Gregory Weitsman, Clare J. Wilhem, Alshad S. Lalani, Irmina Diala, Rachel A. Freedman, Nancy U. Lin, David B. Solit, Michael F. Berger, Paul R. Barber, Tony Ng, Michael Offin, James M. Isbell, David R. Jones, Helena A. Yu, Sheeno Thyparambil, Wei‐Li Liao, Anuja Bhalkikar, Fabiola Cecchi, David M. Hyman, Jason S. Lewis, Darren J. Buonocore, Alan L. Ho, Vicky Makker, Jorge S. Reis‐Filho, Pedram Razavi, Maria E. Arcila, Mark G. Kris, John T. Poirier, Ronglai Shen, Junji Tsurutani, Gary A. Ulaner, Elisa de Stanchina, Neal Rosen, Charles M. Rudin, Maurizio Scaltriti - Cancer Discovery 2020 cited by 289

  12. Guidelines for Validation of Next-Generation Sequencing–Based Oncology Panels

    Authors: Lawrence J. Jennings, Maria E. Arcila, Christopher L. Corless, Suzanne Kamel‐Reid, Ira M. Lubin, John D. Pfeifer, Robyn Temple‐Smolkin, Karl V. Voelkerding, Marina N. Nikiforova - Journal of Molecular Diagnostics 2017 cited by 730

  13. Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial

    Authors: Bob T. Li, Ronglai Shen, Darren J. Buonocore, Zachary T. Olah, Ai Ni, Michelle S. Ginsberg, Gary A. Ulaner, Michael Offin, Daniel Feldman, Todd Hembrough, Fabiola Cecchi, Sarit Schwartz, Nick Pavlakis, Stephen Clarke, Helen Won, Edyta B. Brzostowski, Gregory J. Riely, David B. Solit, David M. Hyman, Alexander Drilon, Charles M. Rudin, Michael F. Berger, José Baselga, Maurizio Scaltriti, Maria E. Arcila, Mark G. Kris - Journal of Clinical Oncology 2018 cited by 559

  14. Lactose drives Enterococcus expansion to promote graft-versus-host disease

    Authors: Christoph K. Stein‐Thoeringer, Katherine Nichols, Amina Lazrak, Melissa D. Docampo, Ann E. Slingerland, John Slingerland, Annelie Clurman, Gabriel K. Armijo, Antonio L. C. Gomes, Yusuke Shono, Anna Staffas, Marina Burgos da Silva, Sean M. Devlin, Kate A. Markey, Danica Bajic, R. Pinedo, Anastasia Tsakmaklis, Eric R. Littmann, Alessandro Pastore, Ying Taur, Sébastien Monette, Maria E. Arcila, Amanda J. Pickard, Molly Maloy, Roberta J. Wright, Luigi A. Amoretti, Emily Fontana, Dung Pham, Mohamed A. Jamal, Daniela Weber, Anthony D. Sung, Daigo Hashimoto, Christof Scheid, João B. Xavier, Julia A. Messina, Kristi Romero, M. Lew, Amy Bush, Lauren Bohannon, Kasumi Hayasaka, Yuta Hasegawa, Maria J. G. T. Vehreschild, Justin R. Cross, Doris M. Ponce, Miguel‐Angel Perales, Sergio Giralt, Robert R. Jenq, Takanori Teshima, Ernst Holler, Nelson J. Chao, Eric G. Pamer, Jonathan U. Peled, Marcel R.M. van den Brink - Science 2019 cited by 369

  15. Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes

    Authors: Michael Offin, Joseph M. Chan, Megan Tenet, Hira Rizvi, Ronglai Shen, Gregory J. Riely, Natasha Rekhtman, Yahya Daneshbod, Àlvaro Quintanal-Villalonga, Alexander Penson, Matthew D. Hellmann, Maria E. Arcila, Marc Ladanyi, Dana Pe’er, Mark G. Kris, Charles M. Rudin, Helena A. Yu - Journal of Thoracic Oncology 2019 cited by 448

  16. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

    Authors: Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner, Maria E. Arcila, Mary Beth Beasley, Eric Bernicker, Carol Colasacco, Sanja Đačić, Fred R. Hirsch, Keith M. Kerr, David J. Kwiatkowski, Marc Ladanyi, Jan A. Nowak, Lynette M. Sholl, Robyn Temple‐Smolkin, Benjamin Solomon, Lesley Souter, Erik Thunnissen, Ming‐Sound Tsao, Christina B. Ventura, Murry W. Wynes, Yasushi Yatabe - Archives of Pathology & Laboratory Medicine 2018 cited by 931

  17. Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making

    Authors: Wassim Abida, Joshua Armenia, Anuradha Gopalan, Ryan Brennan, Michael F. Walsh, David Barron, Daniel C. Danila, Dana E. Rathkopf, Michael J. Morris, Susan F. Slovin, Brigit McLaughlin, Kristen Curtis, David M. Hyman, Jeremy C. Durack, Stephen B. Solomon, Maria E. Arcila, Ahmet Zehir, Aijazuddin Syed, Jianjiong Gao, Debyani Chakravarty, Hebert Alberto Vargas, Mark E. Robson, Joseph Vijai, Kenneth Offit, Mark T.A. Donoghue, Adam Abeshouse, Ritika Kundra, Zachary Heins, Alexander Penson, Christopher Harris, Barry S. Taylor, Marc Ladanyi, Diana Mandelker, Liying Zhang, Victor E. Reuter, Philip W. Kantoff, David B. Solit, Michael F. Berger, Charles L. Sawyers, Nikolaus Schultz, Howard I. Scher - JCO Precision Oncology 2017 cited by 531

  18. Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS -Mutant Non–Small Cell Lung Cancer

    Authors: Kathryn C. Arbour, Emmett Jordan, Hyunjae R. Kim, Jordan Dienstag, Helena A. Yu, Francisco Sánchez-Vega, Piro Lito, Michael F. Berger, David B. Solit, Matthew D. Hellmann, Mark G. Kris, Charles M. Rudin, Ai Ni, Maria E. Arcila, Marc Ladanyi, Gregory J. Riely - Clinical Cancer Research 2017 cited by 460

  19. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

    Authors: Justin Jee, Emily S. Lebow, Randy Yeh, Jeeban P. Das, Azadeh Namakydoust, Paul K. Paik, Jamie E. Chaft, Gowtham Jayakumaran, A. Rose Brannon, Ryma Benayed, Ahmet Zehir, Mark T.A. Donoghue, Nikolaus Schultz, Debyani Chakravarty, Ritika Kundra, Ramyasree Madupuri, Yonina R. Murciano‐Goroff, Hai‐Yan Tu, Chong‐Rui Xu, Andrés Martinez, Clare Wilhelm, Jesse Galle, Bobby Daly, Helena A. Yu, Michael Offin, Matthew D. Hellmann, Piro Lito, Kathryn C. Arbour, Marjorie G. Zauderer, Mark G. Kris, Kenneth Ng, Juliana Eng, Isabel R. Preeshagul, W. Victoria Lai, John J. Fiore, Afsheen N. Iqbal, Daniela Molena, Gaetano Rocco, Bernard J. Park, Lee P. Lim, Mark Junjie Li, Candace Tong-Li, Madhawa De Silva, David Chan, Connie I. Diakos, Malinda Itchins, Stephen Clarke, Nick Pavlakis, Adrian V. Lee, Natasha Rekhtman, Jason C. Chang, William D. Travis, Gregory J. Riely, David B. Solit, Mithat Gönen, Valerie W. Rusch, Andreas Rimner, Daniel R. Gomez, Alexander Drilon, Howard I. Scher, Sohrab P. Shah, Michael F. Berger, Maria E. Arcila, Marc Ladanyi, Ross L. Levine, Ronglai Shen, Pedram Razavi, Jorge S. Reis‐Filho, David R. Jones, Charles M. Rudin, James M. Isbell, Bob T. Li - Nature Medicine 2022 cited by 185

  20. Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

    Authors: Zhenfeng Zhang, Jae Cheol Lee, Luping Lin, Victor Olivas, Valerie Au, Thomas LaFramboise, Mohamed Abdel-Rahman, Xiaoqi Wang, Alan D. Levine, Jin Kyung Rho, Yun Jung Choi, Chang‐Min Choi, Sang-We Kim, Se Jin Jang, Young Soo Park, Woo Sung Kim, Dae Ho Lee, Jung‐Shin Lee, Vincent A. Miller, Maria E. Arcila, Marc Ladanyi, Philicia Moonsamy, Charles L. Sawyers, Titus J. Boggon, C. Patrick, Carlota Costa, Miquel Tarón, Rafael Rosell, Balázs Halmos, Trever G. Bivona - Nature Genetics 2012 cited by 1,220

  21. MET-dependent solid tumours — molecular diagnosis and targeted therapy

    Authors: Robin Guo, Jia Luo, Jason C. Chang, Natasha Rekhtman, Maria E. Arcila, Alexander Drilon - Nature Reviews Clinical Oncology 2020 cited by 320

  22. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

    Authors: Eric J. Duncavage, Adam Bagg, Robert P. Hasserjian, Courtney D. DiNardo, Lucy A. Godley, Ilaria Iacobucci, Siddhartha Jaiswal, Luca Malcovati, Alessandro M. Vannucchi, Keyur P. Patel, Daniel A. Arber, Maria E. Arcila, Rafael Bejar, Nancy Berliner, Michael J. Borowitz, Susan Branford, Anna Brown, Catherine Cargo, Hartmut Döhner, Brunangelo Falini, Guillermo Garcia‐Manero, Torsten Haferlach, Eva Hellström‐Lindberg, Annette S. Kim, Jeffery M. Klco, Rami S. Komrokji, Mignon Lee-Cheun Loh, Sanam Loghavi, Charles G. Mullighan, Seishi Ogawa, Attilio Orazi, Elli Papaemmanuil, Andreas Reiter, David M. Ross, Michael R. Savona, Akiko Shimamura, Radek C. Skoda, Françesc Solé, Richard M. Stone, Ayalew Tefferi, Matthew J. Walter, David Wu, Benjamin L. Ebert, Mario Cazzola - Blood 2022 cited by 208

  23. The Genomic Landscape of SMARCA4 Alterations and Associations with Outcomes in Patients with Lung Cancer

    Authors: Adam J. Schoenfeld, Chai Bandlamudi, Jessica A. Lavery, Joseph Montecalvo, Azadeh Namakydoust, Hira Rizvi, Jacklynn V. Egger, Carla P. Concepcion, Sonal Paul, Maria E. Arcila, Yahya Daneshbod, Jason C. Chang, Jennifer L. Sauter, Amanda Beras, Marc Ladanyi, Tyler Jacks, Charles M. Rudin, Barry S. Taylor, Mark T.A. Donoghue, Glenn Heller, Matthew D. Hellmann, Natasha Rekhtman, Gregory J. Riely - Clinical Cancer Research 2020 cited by 283

  24. Accelerating Discovery of Functional Mutant Alleles in Cancer

    Authors: Matthew T. Chang, Tripti Shrestha Bhattarai, Alison M. Schram, Craig M. Bielski, Mark T.A. Donoghue, Philip Jonsson, Debyani Chakravarty, Sarah Phillips, Cyriac Kandoth, Alexander Penson, Alexander N. Gorelick, Tambudzai Shamu, Swati Patel, Christopher Harris, Jianjiong Gao, S. Onur Sumer, Ritika Kundra, Pedram Razavi, Bob T. Li, Dalicia N. Reales, Nicholas D. Socci, Gowtham Jayakumaran, Ahmet Zehir, Ryma Benayed, Maria E. Arcila, Sarat Chandarlapaty, Marc Ladanyi, Nikolaus Schultz, José Baselga, Michael F. Berger, Neal Rosen, David B. Solit, David M. Hyman, Barry S. Taylor - Cancer Discovery 2017 cited by 426